- Conditions
- Peripheral Arterial Disease, Paclitaxel Adverse Reaction, Safety Issues
- Interventions
- Retrospective data collection
- Other
- Lead sponsor
- Beth Israel Deaconess Medical Center
- Other
- Eligibility
- 66 Years and older
- Enrollment
- 168,553 participants
- Healthy volunteers
- Healthy volunteers not accepted
- Timeline
- 2020 – 2024
- U.S. locations
- 1
- States / cities
- Boston, Massachusetts
Search Results
Search by objective public record fields.
Search by query text, NCT ID, condition, intervention, sponsor, city, state, recruitment status, phase, study type, healthy volunteer eligibility, sex, or age. Results come from ClinicalTrials.gov. When the live registry is unavailable, a clearly labeled stored copy may be shown.
These results were retrieved from the live ClinicalTrials.gov registry. Filters and sort order apply to this result list.
Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.
Showing 1–24
of 365
matching trials from the live ClinicalTrials.gov search.
- Conditions
- Carotid Artery Stenosis, Carotid Artery Diseases, Carotid Stenosis
- Interventions
- Carotid artery stenting with Neuroguard IEP System
- Device
- Lead sponsor
- Contego Medical, Inc.
- Industry
- Eligibility
- 20 Years to 80 Years
- Enrollment
- 305 participants
- Healthy volunteers
- Healthy volunteers not accepted
- Timeline
- 2020 – 2025
- U.S. locations
- 28
- States / cities
- Huntsville, Alabama • St. Helena, California • Washington D.C., District of Columbia + 24 more
- Conditions
- Benign Biliary Strictures
- Interventions
- Endoscopic Retrograde Cholangiopancreatography (ERCP)
- Procedure
- Lead sponsor
- University of Florida
- Other
- Eligibility
- 18 Years and older
- Enrollment
- 23 participants
- Healthy volunteers
- Healthy volunteers not accepted
- Timeline
- 2009 – 2015
- U.S. locations
- 1
- States / cities
- Gainesville, Florida
- Conditions
- Peripheral Venous Outflow Obstruction
- Interventions
- vein stent placement
- Device
- Lead sponsor
- Windsor Ting
- Other
- Eligibility
- 18 Years and older
- Enrollment
- 1,000 participants
- Healthy volunteers
- Healthy volunteers not accepted
- Timeline
- 2019 – 2029
- U.S. locations
- 1
- States / cities
- New York, New York
- Conditions
- Atrial Fibrillation, Percutaneous Coronary Intervention
- Interventions
- Dabigatran Etexilate 110mg, Warfarin 3mg, Aspirin, Dabigatran Etexilate 150mg, Clopidogrel or Ticagrelor, Warfarin 5mg, Warfarin 1mg
- Drug
- Lead sponsor
- Boehringer Ingelheim
- Industry
- Eligibility
- 18 Years and older
- Enrollment
- 2,725 participants
- Healthy volunteers
- Healthy volunteers not accepted
- Timeline
- 2014 – 2017
- U.S. locations
- 45
- States / cities
- Birmingham, Alabama • Cottonwood, Arizona • Mesa, Arizona + 41 more
- Conditions
- Carotid Stenosis
- Interventions
- Carotid PTA and stenting
- Device
- Lead sponsor
- SPSI d.b.a Capital Cardiovascular Associates
- Other
- Eligibility
- 18 Years and older
- Enrollment
- 154 participants
- Healthy volunteers
- Healthy volunteers not accepted
- Timeline
- 2004 – 2017
- U.S. locations
- 1
- States / cities
- Camp Hill, Pennsylvania
- Conditions
- Primary Open Angle Glaucoma
- Interventions
- iStent, Cataract surgery
- Device · Procedure
- Lead sponsor
- Glaukos Corporation
- Industry
- Eligibility
- 22 Years and older
- Enrollment
- 360 participants
- Healthy volunteers
- Healthy volunteers not accepted
- Timeline
- 2013 – 2021
- U.S. locations
- 14
- States / cities
- Irvine, California • Montebello, California • Aurora, Colorado + 11 more
- Conditions
- Liver Cirrhoses, Portal Hypertension Related to Cirrhosis, Severe Obesity, TIPS
- Interventions
- Transjugular Intrahepatic Portosystemic Shunt (TIPS), Sleeve Gastrectomy, Anti-Obesity Pharmacotherapy (Class Effect), Lifestyle Counseling - Diet & Physical-Activity Program
- Procedure · Drug · Behavioral
- Lead sponsor
- The Cleveland Clinic
- Other
- Eligibility
- 18 Years to 70 Years
- Enrollment
- 70 participants
- Healthy volunteers
- Healthy volunteers not accepted
- Timeline
- 2025 – 2034
- U.S. locations
- 1
- States / cities
- Cleveland, Ohio
- Conditions
- Pseudotumor Cerebri, Idiopathic Intracranial Hypertension (IIH)
- Interventions
- Dural Venous Sinus Stenting, Cerebrospinal Fluid Shunting
- Device
- Lead sponsor
- St. Joseph's Hospital and Medical Center, Phoenix
- Other
- Eligibility
- 18 Years and older
- Enrollment
- 80 participants
- Healthy volunteers
- Healthy volunteers not accepted
- Timeline
- 2020 – 2025
- U.S. locations
- 2
- States / cities
- Phoenix, Arizona • Seattle, Washington
- Conditions
- Brain Diseases, Cardiovascular Diseases, Central Nervous System Diseases, Cerebrovascular Disorders, Ischemia, Nervous System Diseases, Pathologic Processes, Stroke, Ischemic, Stroke, Acute, Vascular Diseases
- Interventions
- Mechanical Thrombectomy using the pRESET Thrombectomy device, Mechanical Thrombectomy using the Solitaire Revascularization Device
- Device
- Lead sponsor
- phenox Inc.
- Industry
- Eligibility
- 18 Years and older
- Enrollment
- 340 participants
- Healthy volunteers
- Healthy volunteers not accepted
- Timeline
- 2019 – 2022
- U.S. locations
- 19
- States / cities
- Scottsdale, Arizona • Santa Monica, California • Coral Gables, Florida + 15 more
- Conditions
- Coronary Arterial Disease (CAD), de Novo Lesions in Native Coronary Arteries
- Interventions
- Drug Eluting Balloon, Drug eluting stent, Plain old balloon angioplasty
- Device · Procedure
- Lead sponsor
- Boston Scientific Corporation
- Industry
- Eligibility
- 18 Years and older
- Enrollment
- 1,616 participants
- Healthy volunteers
- Healthy volunteers not accepted
- Timeline
- 2025 – 2032
- U.S. locations
- 47
- States / cities
- Jonesboro, Arkansas • La Jolla, California • Los Angeles, California + 39 more
- Conditions
- Stroke, Ischemia
- Interventions
- EmboTrap® Revascularization Device
- Device
- Lead sponsor
- Neuravi Inc.
- Industry
- Eligibility
- 18 Years to 85 Years
- Enrollment
- 228 participants
- Healthy volunteers
- Healthy volunteers not accepted
- Timeline
- 2015 – 2017
- U.S. locations
- 9
- States / cities
- Los Angeles, California • San Jose, California • Miami, Florida + 6 more
- Conditions
- Kidney Calculi
- Interventions
- Ureteroscopy
- Procedure
- Lead sponsor
- Vanderbilt University Medical Center
- Other
- Eligibility
- 18 Years and older
- Enrollment
- 103 participants
- Healthy volunteers
- Healthy volunteers not accepted
- Timeline
- 2019 – 2026
- U.S. locations
- 6
- States / cities
- Los Angeles, California • Sacramento, California • San Diego, California + 3 more
- Conditions
- Cardiovascular Diseases, Heart Diseases, Myocardial Infarction, Coronary Disease, Arrhythmia, Ventricular Fibrillation
- Interventions
- PCI, Optimal Medical Therapy
- Procedure · Drug
- Lead sponsor
- University of Maryland, Baltimore
- Other
- Eligibility
- Not listed
- Enrollment
- 300 participants
- Healthy volunteers
- Healthy volunteers not accepted
- Timeline
- 2002 – 2006
- U.S. locations
- 1
- States / cities
- Stony Brook, New York
- Conditions
- Primary Open Angle Glaucoma (POAG)
- Interventions
- CyPass Micro-Stent, Cataract Surgery
- Device · Procedure
- Lead sponsor
- Alcon Research
- Industry
- Eligibility
- 45 Years and older
- Enrollment
- 282 participants
- Healthy volunteers
- Healthy volunteers not accepted
- Timeline
- 2016 – 2018
- U.S. locations
- 22
- States / cities
- Glendale, Arizona • Fayetteville, Arkansas • La Jolla, California + 19 more
- Conditions
- Carotid Artery Diseases
- Interventions
- CGuard Prime 80cm stent system
- Device
- Lead sponsor
- InspireMD
- Industry
- Eligibility
- 18 Years to 79 Years
- Enrollment
- 50 participants
- Healthy volunteers
- Healthy volunteers not accepted
- Timeline
- 2024 – 2027
- U.S. locations
- 8
- States / cities
- Sacramento, California • Indianapolis, Indiana • Minneapolis, Minnesota + 5 more
- Conditions
- Abdominal Aortic Aneurysm, AAA
- Interventions
- Endurant Evo AAA Stent Graft System, Endovascular aneurysm repair (EVAR)
- Device · Procedure
- Lead sponsor
- Medtronic Cardiovascular
- Industry
- Eligibility
- 18 Years and older
- Enrollment
- 139 participants
- Healthy volunteers
- Healthy volunteers not accepted
- Timeline
- 2015 – 2021
- U.S. locations
- 14
- States / cities
- San Diego, California • Stanford, California • Washington D.C., District of Columbia + 11 more
- Conditions
- Acute Coronary Syndrome, High Bleeding Risk
- Interventions
- BioFreedom™ Drug Coated Coronary Stent System, Antiplatelet Drug
- Device · Drug
- Lead sponsor
- Biosensors Europe SA
- Industry
- Eligibility
- Not listed
- Enrollment
- 1,203 participants
- Healthy volunteers
- Healthy volunteers not accepted
- Timeline
- 2017 – 2021
- U.S. locations
- 39
- States / cities
- Huntsville, Alabama • Hot Springs, Arkansas • La Jolla, California + 34 more
- Conditions
- Acute Myocardial Infarction, Restenoses, Coronary, Coronary Artery Lesions, Venous Embolism, Arterial Embolism
- Interventions
- Coronary and peripheral stents, Pacing catheters, Vascular plugs, Measurement and imaging (FFR and OCT), Peripheral dilatation catheters, Coronary dilatation catheters, Coronary and peripheral guidewires, Vessel closure/compression devices, Vascular access introducers
- Device
- Lead sponsor
- Abbott Medical Devices
- Industry
- Eligibility
- 18 Years and older
- Enrollment
- 3,784 participants
- Healthy volunteers
- Healthy volunteers not accepted
- Timeline
- 2020 – 2031
- U.S. locations
- 7
- States / cities
- Birmingham, Alabama • Little Rock, Arkansas • Los Angeles, California + 4 more
- Conditions
- Cholangiocarcinoma
- Interventions
- ERCP and Photodynamic Therapy, ERCP only
- Procedure
- Lead sponsor
- Weill Medical College of Cornell University
- Other
- Eligibility
- 18 Years and older
- Enrollment
- 50 participants
- Healthy volunteers
- Healthy volunteers not accepted
- Timeline
- 2010 – 2011
- U.S. locations
- 1
- States / cities
- Charlotteville, Virginia
- Conditions
- Acute Coronary Syndrome, Myocardial Infarction, Coronary Artery Disease, Percutaneous Coronary Intervention
- Interventions
- CGT-2168 (clopidogrel 75 mg/omeprazole 20 mg) and aspirin, Plavix (clopidogrel 75 mg) and aspirin
- Drug
- Lead sponsor
- Cogentus Pharmaceuticals
- Industry
- Eligibility
- 21 Years and older
- Enrollment
- 5,000 participants
- Healthy volunteers
- Healthy volunteers not accepted
- Timeline
- 2007 – 2009
- U.S. locations
- 247
- States / cities
- Alexander City, Alabama • Birmingham, Alabama • Geneva, Alabama + 205 more
- Conditions
- Pancreatitis, Acute Necrotizing
- Interventions
- EUS-guided transluminal drainage of necrotic collection
- Procedure
- Lead sponsor
- Orlando Health, Inc.
- Other
- Eligibility
- 18 Years and older
- Enrollment
- 104 participants
- Healthy volunteers
- Healthy volunteers not accepted
- Timeline
- 2026 – 2029
- U.S. locations
- 1
- States / cities
- Orlando, Florida
- Conditions
- Cognition Disorder, Stroke, Occlusion Carotid
- Interventions
- Endovascular intervention, Aspirin and Clopidogrel (maximal medical Therapy)
- Procedure · Drug
- Lead sponsor
- Duke University
- Other
- Eligibility
- 21 Years to 90 Years
- Enrollment
- 25 participants
- Healthy volunteers
- Healthy volunteers not accepted
- Timeline
- 2020 – 2024
- U.S. locations
- 2
- States / cities
- Iowa City, Iowa • Durham, North Carolina
- Conditions
- Aortic Dissection
- Interventions
- GORE® Ascending Stent Graft (ASG device)
- Device
- Lead sponsor
- W.L.Gore & Associates
- Industry
- Eligibility
- 18 Years and older
- Enrollment
- 112 participants
- Healthy volunteers
- Healthy volunteers not accepted
- Timeline
- 2025 – 2031
- U.S. locations
- 22
- States / cities
- Birmingham, Alabama • Los Angeles, California • Palo Alto, California + 19 more